Mankind Pharma Limited (NSE:MANKIND)
India · Delayed Price · Currency is INR 2,080.00
+1.00 (0.05%)
Apr 13, 2026, 3:30 PM IST
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 858.27 billion as of April 13, 2026. Its market cap has decreased by -7.33% in one year.
Market Cap
858.27B
Enterprise Value
909.40B
Revenue
139.14B
Ranking
n/a
PE Ratio
48.12
Stock Price
2,080.00
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 858.27B, an increase of 50.64%. That is a compound annual growth rate of 15.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 857.61B | -5.42% |
| Dec 31, 2025 | 906.73B | -23.70% |
| Dec 31, 2024 | 1.19T | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.62T |
| Cipla | 993.17B |
| Zydus Lifesciences | 921.11B |
| Aurobindo Pharma | 783.73B |
| Alkem Laboratories | 650.43B |
| Glenmark Pharmaceuticals | 610.46B |
| Laurus Labs | 592.95B |
| Ipca Laboratories | 369.44B |